| Financial Year |
March 31 2023 |
| Monetary Funds |
211,700,296.84 |
| Held-for-trading Financial Assets |
481,353,735.60 |
| Notes Receivable |
-- |
| Accounts Receivable |
129,180,257.89 |
| Advances to Suppliers |
14,540,715.20 |
| Other Receivables |
4,449,880.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
12,050,759.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,755,596.81 |
| Total Current Assets |
858,657,046.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
75,117,349.60 |
| Under-construction Projects |
672,986.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,619,897.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,285,222.43 |
| Deferred Income Tax Assets |
3,993,093.17 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
118,188,911.12 |
| Total Assets |
976,845,957.58 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
50,439,503.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,178,330.11 |
| Taxes Payable |
3,969,249.18 |
| Interest Payable |
-- |
| Dividend Payable |
116,544.00 |
| Other payables |
6,480,689.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,423,700.42 |
| Other Current Liabilities |
12,493,610.54 |
| Sub-Total of Current Liabilities |
120,225,106.44 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,964,828.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,286,967.31 |
| Total Liabilities |
139,512,073.75 |
| Paid-In Capital(Or Share Stock) |
131,557,770.00 |
| Capital Surplus |
482,626,487.40 |
| Surplus Reserve |
35,780,230.37 |
| LESS:Treasury Stock |
17,579,197.66 |
| Undistributed Profits |
208,097,530.97 |
| Minority Stockholder's Interest |
-3,294,039.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
840,627,922.99 |
| Owner's Equity（Stockholder's Equity） |
837,333,883.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
976,845,957.58 |
